Abstract: Systems for performing methods which include receiving by a VPN server, from a VPN client operating on a computing device, over a VPN connection a first message including a first IP address. The VPN server determines a hostname based on the first IP address, resolves the hostname to a second IP address, and transmits the first message to a network device at the second IP address.

Abstract: A system, computer-readable storage medium, and method for secure network communication. A first device employs a first secret to establish a stream between the first and a second device. A third key, first ciphertext based on a first key, and hash of the first key are received from the second device by the first. A second key is applied to recover a second secret from the first ciphertext. The third key is encrypted to generate a second ciphertext including a third secret. Fourth and fifth keys are derived based on the first, second, and third secrets. A message authentication code is generated based on the fourth and third keys, first ciphertext, hash of the first key, and second ciphertext. The second ciphertext and message authentication code are transmitted by the first to the second device, and the fifth key is employed by the first device to modify the stream.

Abstract: A system, computer-readable storage medium, and method for secure network communication. A first device employs a first secret to establish a stream between the first and a second device. A third key, first ciphertext based on a first key, and hash of the first key are received from the second device by the first. A second key is applied to recover a second secret from the first ciphertext. The third key is encrypted to generate a second ciphertext including a third secret. Fourth and fifth keys are derived based on the first, second, and third secrets. A message authentication code is generated based on the fourth and third keys, first ciphertext, hash of the first key, and second ciphertext. The second ciphertext and message authentication code are transmitted by the first to the second device, and the fifth key is employed by the first device to modify the stream.

Abstract: The invention relates to compositions for retaining soil moisture and improving plant growth in dry soils, which, together with one or more moisture retaining materials and wetting agents, comprises iron(III) oxides and optionally potassium metabisulfite [borken (HU), E224] as potentiating agent. The iron(III) oxides preferably are microparticulate. The composition Suitably comprises iron(III)oxides and potassium metabisulfite as potentiating agent. Other aspects of the invention relate to binding the moisture content of soils, as well as compositions for use in enhancing the efficacy of Soil retaining compositions.

Abstract: The invention is related to nucleic acids encoding resistance proteins, avirulence proteins, or both, wherein at least one of the proteins include at least one amino acid substitution in comparison to the wild type amino acid sequence of the resistance and/or avirulence protein, said substitution leading to a decrease of cell death during a hypersensitive reaction. Furthermore, the invention does also encompass an expression cassette, a vector, a cell, a plant, plant tissue or plant seed comprising on of the nucleic acids or one of the proteins. Finally, the invention provides a method for increasing a plant's resistance towards at least one plant pathogen.

Abstract: The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X?×Y?×Z. The ATI is used to assess the radio-responsiveness i.e. sensitivity or resistance to radiation treatment, of a cancer i.e. a tumor/neoplasm. In a preferred embodiment, the present invention relates to a method of generating the ATI, assessing the radio-responsiveness of a tumor/neoplasm based on the ATI and, based on the assessment, either treating or not treating the tumor with radiation.

Abstract: The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X?×Y?×Z. The ATI is used to assess the radio-responsiveness i.e. sensitivity or resistance to radiation treatment, of a cancer i.e. a tumor/neoplasm. In a preferred embodiment, the present invention relates to a method of generating the ATI, assessing the radio-responsiveness of a tumor/neoplasm based on the ATI and, based on the assessment, either treating or not treating the tumor with radiation.

Abstract: The invention relates to compositions for retaining soil moisture and improving plant growth in dry soils, which, together with one or more moisture retaining materials and wetting agents, comprises iron(III) oxides and optionally potassium metabisulfite [borken (HU), E224] as potentiating agent. The iron(III) oxides preferably are microparticulate. The composition Suitably comprises iron(III)oxides and potassium metabisulfite as potentiating agent. Other aspects of the invention relate to binding the moisture content of soils, as well as compositions for use in enhancing the efficacy of Soil retaining compositions.

Abstract: The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X?×Y?×Z. The ATI is used to assess the radio-responsiveness i.e. sensitivity or resistance to radiation treatment, of a cancer i.e. a tumour/neoplasm. In a preferred embodiment, the present invention relates to a method of generating the ATI, assessing the radio-responsiveness of a tumour/neoplasm based on the ATI and, based on the assessment, either treating or not treating the tumour with radiation.

Abstract: The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X?xY?xZ. The ATI is used to assess the radio-responsiveness i.e. sensitivity or resistance to radiation treatment, of a cancer i.e. a tumour/neoplasm. In a preferred embodiment, the present invention relates to a method of generating the ATI, assessing the radio-responsiveness of a tumour/neoplasm based on the ATI and, based on the assessment, either treating or not treating the tumour with radiation.

Abstract: The invention relates to compositions for retaining soil moisture and improving plant growth in dry soils, which, together with one or more moisture retaining materials and wetting agents, comprises iron(III)oxides and optionally potassium metabisulfite [borken (HU), E224] as potentiating agent. The iron(III)oxides preferably are microparticulate. The composition suitably comprises iron(III)oxides and potassium metabisulfite as potentiating agent. Other aspects of the invention relate to binding the moisture content of soils, as well as compositions for use in enhancing the efficacy of soil retaining compositions.

Abstract: A method for detecting a microorganism comprising reducing the complexity of a microbial genome or microbial nucleic acid by generating a simplified form of the microbial genome or microbial nucleic acid in which substantially all of the positions naturally occupied by cytosines are occupied by uracil or thymine; and assaying for a microbial specific nucleic acid in the simplified form of the microbial genome or microbial nucleic acid, wherein presence of the microbial specific nucleic acid is indicative of the microorganism.

Abstract: The invention relates to an assay for determining a health state of a subject using a combination of detecting the presence of a virus and detecting the presence of a genomic target or marker indicative of a health state.

Abstract: A method for determining the methylation status of a potential methylation site in genomic nucleic acid comprising treating genomic nucleic acid with an agent which modifies cytosine bases but does not modify 5methyl-cytosine bases under conditions to form a.

Abstract: A method for simplification of a microbial genome or microbial nucleic acid comprising treating microbial genome or nucleic acid with an agent that modifies cytosine to form derivative microbial nucleic acid and amplifying the derivative microbial nucleic acid to produce a simplified form of the microbial genome or nucleic acid.

Abstract: A method for simplification of a microbial genome or microbial nucleic acid comprising treating microbial genome or nucleic acid with an agent that modifies cytosine to form derivative microbial nucleic acid and amplifying the derivative microbial nucleic acid to produce a simplified form of the microbial genome or nucleic acid.

Abstract: A method for detecting the presence of a target nucleic acid in a sample including treating a sample containing nucleic acid with an agent that modifies unmethylated cytosine; providing to the treated sample a detector ligand in the form of an intercalating nucleic acid (INA) capable of binding to a target region of nucleic acid, and allowing sufficient time for the detector ligand to bind to the target nucleic acid, and detecting binding of the detector ligand to nucleic acid molecule in the sample to indicate the presence of the target nucleic acid.